An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shockRobert F. Grover, Jean‐Louis Vincent, David I. Watson et al.|Critical Care Medicine|1999Cited by 200
Administration of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)*Jan Bakker, Jukka Takala, Robert F. Grover et al.|Critical Care Medicine|2004Cited by 196
Systematic review and meta-analysis of laparoscopic mesh versus suture repair of hiatus hernia: objective and subjective outcomesChao Zhang, Zhonggao Wang, Tao Luo et al.|Surgical Endoscopy|2017Cited by 111